Web12 Jul 2024 · “At Tempus, we have also found that xF is especially beneficial when used in combination with standard tissue sequencing for patients with advanced cancer, and therefore it is important to offer oncologists both a liquid biopsy and solid tumor assay on a single platform.” WebThe X9 High-Throughput Genomics System enables high data output with more than 9,000 individual nanoliter-volume reactions in a single run, ensuring cost-effective, comprehensive sample profiling with minimal operator contribution. Instead of using 96 plates worth of reagents, plastic and labor, X9 can reduce an experiment to a single chip.
Integrated genomic profiling expands clinical options for …
Web6 Apr 2024 · Introduction of the ‘precision medicine’ approach has seen its most significant advances in the field of oncology. The key scientific principle behind this approach is to … WebA comprehensive analysis demonstrates that OC organoids maintained tumors’ histological characteristics and genomic landscape (nuclear and cellular atypia, and biomarker expression, such as p53 and PAX8), remained highly similar at the gene expression, even after extended passaging, recapitulated OC hallmarks, such as somatic single-nucleotide … crystal township tale
Clinical validation of the tempus xT next-generation targeted …
Web12 Jul 2024 · xF is part of Tempus’ library of assays conducted in its CLIA-certified and CAP-accredited laboratory, which also includes xE, an assay that analyzes the whole exome … Web30 Mar 2024 · Beaubier N, Tell R, Lau D, et al. Clinical validation of the tempus xT next-generation targeted oncology sequencing assay. Oncotarget. 2024;10(24):2384 … Web9 Feb 2024 · Tempus, a leader in artificial intelligence and precision medicine, today announced the launch of its new germline sequencing assay, xG, a 52-gene panel that … dynamic firearms